RLE Outcomes With Bilateral Implantation of Odyssey IOLs
NCT ID: NCT06979557
Last Updated: 2025-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2025-07-21
2026-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
NCT06550375
Odyssey Evaluation in Post LASIK Patients
NCT07260695
Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL
NCT05991960
Visual Outcomes of Tecnis Symfony Opti-Blue EDOF Intraocular Lens (IOL)
NCT06500416
Visual Outcomes After Presbyopic Lens Exchange
NCT03790592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Odyssey IOL
Bilateral Implantation with the Odyssey IOL
Odyssey IOL
Bilateral implantation with the Odyssey IOL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Odyssey IOL
Bilateral implantation with the Odyssey IOL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sengi
INDUSTRY
Mann Eye Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Phillip Brunson, OD
Role: PRINCIPAL_INVESTIGATOR
Mann Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mann Eye Institute
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PB-25-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.